En Es
Categories

Industry News

AI Predicts Alzheimer’s Disease Years before Diagnosis

By Medimaging International staff writers
23 Nov 2018

Image: Saliency map of deep learning model Inception V3 on the classification of Alzheimer disease. (a) A representative saliency map with anatomic overlay in 77-year-old man. (b) Average saliency map over 10 percent of Alzheimer’s Disease Neuroimaging Initiative set. (c) Average saliency map over independent test set. The closer a pixel color is to the A new study on the application of deep learning (DL) to detect changes in brain metabolism predictive of Alzheimer’s disease (AD) has found that artificial intelligence (AI) improves the ability of brain imaging to predict AD.

Timely diagnosis of AD is extremely important, although early diagnosis has proven to be challenging. Research has linked the disease process to changes in metabolism, as shown by glucose uptake in certain regions of the brain, although these changes can be difficult to recognize.

The researchers trained the DL algorithm using an 18-F-fluorodeoxyglucose PET (FDG-PET) scan. They had access to data from the Alzheimer’s Disease Neuroimaging Initiative (ADNI), a major multi-site study focused on clinical trials to improve prevention and treatment of the disease. The ADNI dataset included more than 2,100 FDG-PET brain images from 1,002 patients. The researchers trained the DL algorithm on 90% of the dataset and then tested it on the remaining 10% of the dataset. Finally, the researchers tested the algorithm on an independent set of 40 imaging exams from 40 patients that it had never studied. The algorithm achieved 100% sensitivity at detecting the disease an average of more than six years prior to the final diagnosis.

According to the researchers, the algorithm could be a useful tool to complement the work of radiologists — especially in conjunction with other biochemical and imaging tests — in providing an opportunity for early therapeutic intervention. The researchers will now focus on training the DL algorithm to look for patterns associated with the accumulation of beta-amyloid and tau proteins, abnormal protein clumps and tangles in the brain that are markers specific to AD.

“If we diagnose Alzheimer’s disease when all the symptoms have manifested, the brain volume loss is so significant that it’s too late to intervene,” said study co-author Jae Ho Sohn, MD, from the Radiology & Biomedical Imaging Department at the University of California in San Francisco (UCSF). “If we can detect it earlier, that’s an opportunity for investigators to potentially find better ways to slow down or even halt the disease process.”

Related Links:
University of California in San Francisco



E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

20 Feb 2019
RSNA Debuts New Journal Focused on AI in Radiology
The Radiological Society of North America has published the first issue of its new online journal, Radiology: Artificial Intelligence.
Read More
20 Feb 2019
Researchers Publish Chest X-Ray Dataset to Train AI Models
Researchers from the Stanford University School of Medicine have published CheXpert, a large dataset of chest X-rays and competition for automated chest X-ray interpretation, which features uncertainty labels and radiologist-labeled reference standard evaluation sets.
Read More
20 Feb 2019
ECR 2019 Debuts Artificial Intelligence Exhibition
The Artificial Intelligence Exhibition (AIX) made its grand debut at the 2019 European Congress of Radiology (ECR) annual meeting held on Feb. 27-March 3 in Vienna, Austria, bringing AI to the heart of the technical exhibition.
Read More
20 Feb 2019
AI-based Software for Chest X-rays Receives CE Certification
Oxipit, a provider of AI-based medical imaging solutions, has received CE certification for its ChestEye radiology imaging suite.
Read More
20 Feb 2019
Alliance for AI in Healthcare Formally Launched
The Alliance for Artificial Intelligence in Healthcare was formally launched following the inaugural meeting of its 22-person board of directors.
Read More
20 Feb 2019
Global Digital Pathology Market to Reach USD 600 Million by 2022
The global digital pathology market is projected to grow at a CAGR of 8.5% from 2017-2022 to reach USD 600 million by 2022, despite the presence of headwinds that are suppressing market potential and limiting its growth.
Read More
07 Feb 2019
Puritan Medical Products Kicks Off 100th Anniversary Celebrations
Puritan Medical Products Co. LLC, a global manufacturer of single-use products, is all set to celebrate its 100th anniversary this year.
Read More
07 Feb 2019
New AI System Prioritizes Chest X-Rays Containing Critical Findings
A team of UK researchers has trained an artificial intelligence (AI) system to interpret and prioritize abnormal chest X-rays with critical findings, thereby creating the potential for reducing the backlog of exams and bringing urgently needed care to patients more quickly.
Read More
07 Feb 2019
Global MRI Systems Market to Grow by USD 1.5 Billion in 2019-2023
The global MRI systems market size is projected to grow at a CAGR of more than 5%, or by almost USD 1.58 billion, during the forecast period 2019-2023, driven primarily by technological advances.
Read More
Copyright © 2000-2019 TradeMed.com. All rights reserved. | Terms And Conditions